These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1586902)
21. [Combined insulin and sulfonylurea treatment in diabetes mellitus]. Ravina A; Minuhin O Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394 [No Abstract] [Full Text] [Related]
22. [40 years of using sulfonylurea derivatives for treatment of diabetes]. Sieradzki J Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529 [TBL] [Abstract][Full Text] [Related]
23. Current perioperative treatment of patients with type 1 and type 2 diabetes. Ghirlanda G; Mancini L Clin Podiatr Med Surg; 2007 Jul; 24(3):365-82; vii. PubMed ID: 17613381 [TBL] [Abstract][Full Text] [Related]
24. Defining the role of incretin mimetic therapy in the management of type 2 diabetes. Unger J; Nadeau DA J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341 [TBL] [Abstract][Full Text] [Related]
26. Sulphonylureas in the treatment of non-insulin-dependent diabetes. Ferner RE; Alberti KG Q J Med; 1989 Nov; 73(271):987-95. PubMed ID: 2695959 [No Abstract] [Full Text] [Related]
27. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Dagogo-Jack S; Santiago JV Arch Intern Med; 1997 Sep; 157(16):1802-17. PubMed ID: 9290539 [TBL] [Abstract][Full Text] [Related]
28. [Mode of action of hypoglycemic sulfanilamides]. Girardin E; Conte Devolx B Therapie; 1991; 46(4):311-4. PubMed ID: 1948807 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus]. Procacci V; Giovine A; Roberto MG; Di Reda N; Lasorsa G; Vendemiale G; Stufano N; Altomare E Boll Soc Ital Biol Sper; 1988 Sep; 64(9):817-24. PubMed ID: 3072977 [No Abstract] [Full Text] [Related]
30. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus. Goo AK; Carson DS; Bjelajac A J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of hyperglycemia in adult-onset diabetes mellitus]. Yki-Järvinen H Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855 [No Abstract] [Full Text] [Related]
33. [The treatment characteristics of non-insulin-dependent diabetes mellitus]. Balabolkin MI; Kreminskaia VM Ter Arkh; 1996; 68(10):5-11. PubMed ID: 9026945 [No Abstract] [Full Text] [Related]
34. [Factors responsible for fasting hyperglycemia in the non-insulin-dependent diabetic patient]. Tappy L Rev Med Suisse Romande; 1993 Sep; 113(9):699-701. PubMed ID: 8210897 [No Abstract] [Full Text] [Related]
35. Combined insulin and oral sulfonylureas--how sweet it isn't! Ponte CD DICP; 1990 Dec; 24(12):1234-5. PubMed ID: 2089839 [No Abstract] [Full Text] [Related]
36. Insulin and oral sulfonylureas in the treatment of diabetes mellitus. White JR Am Pharm; 1992 Aug; NS32(8):39-43. PubMed ID: 1524021 [No Abstract] [Full Text] [Related]
37. Management of diabetes in patients with cancer. Jacob P; Chowdhury TA QJM; 2015 Jun; 108(6):443-8. PubMed ID: 25362096 [TBL] [Abstract][Full Text] [Related]
38. [Glucagon-like peptide-1 analogues in type 2 diabetes: beyond glycemic control]. Gensini GF G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 2):5S-6S. PubMed ID: 21361049 [No Abstract] [Full Text] [Related]
39. [Circaseptan hyperglycemia in a case of insulin-dependent diabetes mellitus with Down's syndrome]. Yamaguchi K; Fukushima H; Ikebe S; Sano M; Oribe Y; Uzawa H Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1211-7. PubMed ID: 6229591 [No Abstract] [Full Text] [Related]